Cargando…
Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia
Leukemia is one of the leading childhood malignancies, with acute lymphoblastic leukemia (ALL) being the most common type. Invasive fungal disease is a concerning problem also at pediatric hemato-oncology units. Available guidelines underline the need for antifungal prophylaxis and give recommendati...
Autores principales: | Sienkiewicz-Oleszkiewicz, Beata, Salamonowicz-Bodzioch, Małgorzata, Słonka, Justyna, Kałwak, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380616/ https://www.ncbi.nlm.nih.gov/pubmed/37510753 http://dx.doi.org/10.3390/jcm12144637 |
Ejemplares similares
-
Factors Influencing the Safety and Efficiency of Antifungal Prophylaxis with Posaconazole in Children with Hematological Diseases: From Genetics to Polypharmacotherapy
por: Sienkiewicz-Oleszkiewicz, Beata, et al.
Publicado: (2019) -
The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder
por: Szmit, Zofia, et al.
Publicado: (2022) -
Viral Infection Profile in Children Treated for Acute Lymphoblastic Leukemia—Results of Nationwide Study
por: Zawitkowska, Joanna, et al.
Publicado: (2022) -
The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities
por: Meyer, Lauren K., et al.
Publicado: (2019) -
Orphan Drugs, Compounded Medication and Pharmaceutical Commons
por: Hendrickx, Kim, et al.
Publicado: (2021)